Back to Search
JOSEPH BOKAR, MD
MD
Hematology & Oncology Physician
NPI: 1881619492Individual
Specialties, Licenses & Credentials
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
35-062477(OH)
Research & Publications (6)
A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome.
PMID 19265494·Thyroid·2009
3-trial
Phase I trial of docetaxel given every 3 weeks and daily lenalidomide in patients with advanced solid tumors.
PMID 19011760·Invest New Drugs·2009
3-trial
Phase I trial of docetaxel and thalidomide: a regimen based on metronomic therapeutic principles.
PMID 18470481·Invest New Drugs·2008
3-trial
Induction of sporulation in Saccharomyces cerevisiae leads to the formation of N6-methyladenosine in mRNA: a potential mechanism for the activity of the IME4 gene.
PMID 12384598·Nucleic Acids Res·2002
7-preclinical
SR proteins Asf/SF2 and 9G8 interact to activate enhancer-dependent intron D splicing of bovine growth hormone pre-mRNA in vitro.
PMID 11142383·RNA·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 11100 EUCLID AVE
CLEVELAND, OH 44106 - Phone
- (216) 844-8500
Quick Facts
- NPI
- 1881619492
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 6
Are you this provider?
Claim Your Profile